Incorporated in 1989, Sigachi Industries Limited is one of the largest manufacturers of Microcrystalline Cellulose (MCC) in India. MCC is primarily widely used as an excipient (carrier or supporting material) for finished dosages in the pharmaceutical industry. Here’s all you need to know about this IPO.
Reasons for going public
Top shareholders of the company are:
Here’s a look at the company’s financial status:
Hyderabad-based Sigachi Industries manufactures microcrystalline cellulose (MCC), which is used as excipient (binders, fillers) in pharmaceutical, supplement and food industries. The company has three manufacturing locations in India and is one of the leading MCC makers in India.
The global market for MCC is expected to grow at a CAGR of 7.2% between 2020-2025 and reach $1.4 billion (about ₹10,500 crore) by 2025. The growth is expected to be driven by the rising demand for packaged food and rising demand for pharmaceutical, cosmetic and personal care products. Europe is currently the largest market for MCC and accounts for nearly one third of the market share. India is a relatively smaller market with a size of about ₹300 crore. Sigachi derives more than 70% of its revenues from exports.